重症医学女性领导力障碍:ESICM NEXT与多样性监测组调查
该多中心、观察性、国际在线调查由ESICM NEXT与ESICM多样性与包容性监测组合作设计,于2023年4月1日至2023年10月1日通过邮件和社交网络发放。354名应答者中男性90人(25.42%)、女性264人(74.58%),251人完成调查。结果显示10%-50%的应答者担任领导职务,65%认为存在骚扰等障碍,近半数在会议中被打断,仅47.4%收到会议邀请,仅12%近三年在ESICM会议发言,仅14%享有带薪家庭假、32%获得托儿补贴;55%申请过ESICM职位但报告了骚扰、缺乏财务支持、托儿及语言障碍。作者认为需采取多层面、交叉性策略应对性别歧视与结构性障碍。
要点
- 354名应答者中女性264人(74.58%)、男性90人(25.42%),251人完成调查;10%-50%的应答者担任领导职务。
- 65%的应答者认识到骚扰等障碍;近半数在会议中经历被打断。
- 仅47.4%收到会议邀请,略超半数接受邀请;仅12%近三年在ESICM会议发言,获得主任和同事的支持有限。
- 55%申请过ESICM职位,但报告了骚扰、缺乏财务支持、托儿及语言障碍等障碍。
- 仅14%享有带薪家庭假,32%获得托儿补贴;鼓励家庭参与、降低费用、提供托儿和经济支持可提升会议参与。
适用人群与场景
- 重症医学领域的女性与男性专业人员,通过邮件和社交网络受邀参与国际在线调查。
研究设计与关键结果
- 研究类型:多中心、观察性、国际在线调查;数据收集时间为2023年4月1日至2023年10月1日。
- 样本量:354名应答者,其中男性90人(25.42%)、女性264人(74.58%);251人完成调查。
- 领导岗位:10%-50%的应答者担任领导职务;65%认识到骚扰等障碍;近半数在会议中经历被打断。
- 会议参与:仅47.4%收到会议邀请,略超半数接受邀请;仅12%近三年在ESICM会议发言,获得主任和同事的支持有限。
- 职业申请:55%申请过ESICM职位,但报告了骚扰、缺乏财务支持、托儿及语言障碍等障碍。
- 家庭支持:仅14%享有带薪家庭假,32%获得托儿补贴。
- 作者认为鼓励家庭参与、降低费用、提供托儿和经济支持可提升会议参与;参与职业发展目标有效沟通课程、女性领导力与导师计划可提供见解和成长机会;与人力资源和领导盟友合作对克服障碍、促进女性职业发展至关重要。
证据类型、等级与局限
- 证据类型:多中心、观察性、国际在线调查。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为与人力资源和领导盟友合作对克服障碍、促进女性职业发展至关重要。
- 作者认为鼓励家庭参与、降低费用、提供托儿和经济支持可提升会议参与。
- 作者认为参与职业发展目标有效沟通课程、女性领导力与导师计划可提供有价值的见解和成长机会。
- 作者认为应对女性领导力障碍需采取多层面、交叉性方法,考虑性别歧视、结构性障碍和针对性策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The underrepresentation of women in leadership remains a pervasive issue, prompting a critical examination of support mechanisms within professional settings. Previous studies have identified challenges women face, ranging from limited visibility to barriers to career advancement. This survey aims to investigate perceptions regarding the effectiveness of women's leadership programs, mentoring initiatives, and a specialized communication course. Particularly it specifically targets addressing the challenges encountered by professional women.
METHODS: This multi-center, observational, international online survey was developed in partnership between ESICM NEXT and the ESICM Diversity and Inclusiveness Monitoring Group for Healthcare. Invitations to participate were distributed to both females and men through emails and social networks. Data were collected from April 1, 2023, through October 1, 2023.
RESULTS: Out of 354 respondents, 90 were men (25.42%) and 264 were women (74.58%). Among them, 251 completed the survey, shedding light on the persistent challenges faced by women in leadership roles, with 10%-50% of respondents holding such positions. Women's assertiveness is viewed differently, with 65% recognizing barriers such as harassment. Nearly half of the respondent's experience interruptions in meetings. Only 47.4% receiving conference invitations, with just over half accepting them. A mere 12% spoke at ESICM conferences in the last three years, receiving limited support from directors and colleagues, indicating varied obstacles for female professionals. Encouraging family participation, reducing fees, providing childcare, and offering economic support can enhance conference involvement. Despite 55% applying for ESICM positions, barriers like mobbing, harassment, lack of financial support, childcare, and language barriers were reported. Only 14% had access to paid family leave, while 32% benefited from subsidized childcare. Participation in the Effective Communication Course on Career Advancement Goals and engagement in women's leadership and mentoring programs could offer valuable insights and growth opportunities. Collaborating with Human Resources and leadership allies is crucial for overcoming barriers and promoting women's career growth.
CONCLUSIONS: The urgency of addressing identified barriers to female leadership in intensive care medicine is underscored by the survey's comprehensive insights. A multifaceted and intersectional approach, considering sexism, structural barriers, and targeted strategies, is essential.
参考来源
- De Rosa S, Schaller SJ, Galarza L, et al. Barriers to female leadership in intensive care medicine: insights from an ESICM NEXT & Diversity Monitoring Group Survey. Ann Intensive Care. 2024. PMID: 39158624. doi:10.1186/s13613-024-01358-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。